Global Genetic Testing Market Size And Forecast Report 2024-2030

Global Genetic Testing Market Analysis

The global genetic testing market is projected to reach a value of US$ 37.58 billion by 2030, up from US$ 19.60 billion in 2023, growing at a CAGR of 9.75% from 2024 to 2030. This rapid expansion is driven by a combination of technological advancements, increasing public awareness of genetic health, and a rising demand for personalized medical care. Genetic testing, once a niche service, has become increasingly mainstream, playing a central role in healthcare, ancestry exploration, and even lifestyle optimization.

Request a free sample copy of the report: https://www.renub.com/genetic-testing-market-p.php

Driving Factors for Market Growth

Increased Incidence of Genetic and Chronic Diseases

One of the major drivers behind the market's growth is the rising prevalence of genetic disorders and chronic diseases. Disorders like thalassemia, Down syndrome, cystic fibrosis, and various types of cancer are becoming more prevalent globally. For example, approximately 3,000 to 5,000 children are born with Down syndrome every year, highlighting the growing need for genetic diagnostics to identify, manage, and prevent genetic conditions early. As awareness about genetic diseases expands, more individuals and healthcare professionals are seeking genetic testing for early diagnosis and personalized treatment plans.

Technological Advancements and Cost Reduction

In recent years, advances in genetic testing technologies—such as DNA sequencing and PCR—have made genetic testing more affordable and accessible. The decreasing cost of genetic tests is democratizing access to these services, enabling more individuals to explore their genetic makeup. This trend is supported by an increase in research and development investments, as well as improvements in testing kits for niche therapeutic areas. As testing becomes more affordable, it is poised to reach broader markets, expanding its use in preventive healthcare and personalized medicine.

Growing Demand for Preventive Healthcare

Genetic testing is increasingly seen as a preventive healthcare tool, providing insights into an individual’s genetic predispositions to diseases such as heart disease, cancer, and diabetes. As healthcare continues to shift towards preventive and personalized approaches, individuals are seeking ways to manage health proactively. Genetic testing allows for tailored health plans, early intervention, and risk management, fueling further adoption of these technologies.

Market Segmentation

Diagnostic Testing Leads the Way

Within the genetic testing market, diagnostic testing is one of the most prominent segments. Diagnostic tests are crucial for identifying genetic predispositions to diseases and providing actionable insights for early intervention. These tests are used to detect conditions like cystic fibrosis, muscular dystrophy, and inherited forms of cancer. As healthcare providers increasingly prioritize preventive measures and personalized treatments, diagnostic genetic tests are becoming indispensable tools in clinical practice.

Consumables as a Key Product Category

The consumables segment, which includes reagents, DNA extraction kits, and assay kits, is another vital part of the genetic testing market. As demand for genetic testing grows, so too does the need for high-quality consumables. These products ensure the accuracy and efficiency of genetic tests, and they are used in nearly every phase of the testing process—from sample collection to analysis. The growth of the consumables segment underscores its importance in supporting the genetic testing infrastructure globally.

DNA Sequencing at the Forefront

Among the various genetic testing technologies, DNA sequencing holds a significant share due to its precision and depth of insight. This technology enables comprehensive analysis of the human genome, helping to identify genetic variations that may contribute to diseases. The continuous reduction in sequencing costs, coupled with its ability to provide highly detailed genetic information, makes it an essential tool in genetic diagnostics, personalized treatments, and research applications. As sequencing technology advances, it is likely to play a pivotal role in the expansion of genetic testing across multiple sectors.

Infectious Diseases: A Growing Segment

Infectious diseases are becoming an increasingly important area for genetic testing, especially for identifying pathogens and microbial strains that cause diseases. With the rise of global health threats such as pandemics, rapid and accurate genetic tests are critical in detecting, managing, and controlling infectious diseases. These tests provide real-time insights into virus mutations and help healthcare professionals tailor treatment strategies for better patient outcomes.

Regional Insights

North America: The Leading Market

North America, particularly the United States, is expected to maintain a dominant position in the global genetic testing market. The increasing incidence of genetic disorders, coupled with a high demand for personalized medicine and cancer screening, drives the growth of this market in the region. For example, the American Cancer Society estimates that 1.9 million new cancer cases will be diagnosed in the United States in 2024, prompting greater demand for genetic testing for cancer risk assessment and personalized therapies. The region's advanced healthcare infrastructure, as well as its ongoing focus on genomic research, further strengthens its position in the market.

Europe: Growth in Personalized Medicine

Europe also represents a significant market for genetic testing. Countries like Germany, France, and the United Kingdom are witnessing growth in the adoption of genetic testing technologies. The region's focus on precision medicine and the increasing awareness of genetic diseases contribute to market expansion. Additionally, the European Union's regulatory frameworks, such as the EU In Vitro Diagnostic Regulation (IVDR), are driving innovation and ensuring the quality and safety of genetic testing products.

Asia Pacific: Rapid Market Expansion

The Asia Pacific region is expected to experience one of the highest growth rates in the genetic testing market. Countries like China, India, and Japan are embracing genetic testing for a variety of applications, from cancer screening to genetic counseling. As healthcare systems improve, increasing investments in healthcare infrastructure, and growing awareness about genetic health are driving the adoption of these technologies. Moreover, the rise in genetic diseases and the growing demand for personalized healthcare are fueling the expansion of genetic testing in the region.

Latin America and Middle East & Africa

In regions like Latin America and the Middle East & Africa, genetic testing is emerging as a tool for improving healthcare access and personalized treatments. While these markets are still developing compared to North America and Europe, there is growing interest in using genetic testing for disease prevention, especially in countries like Brazil and Saudi Arabia. The increasing prevalence of chronic diseases, such as heart disease and diabetes, is also contributing to the demand for genetic testing.

Key Players in the Market

Several major players dominate the global genetic testing market, leveraging their research and development capabilities to create innovative testing solutions:

Abbott Laboratories
Danaher Corporation (Cepheid Inc.)
Illumina Inc.
Bio-Rad Laboratories Inc.
F. Hoffmann-La Roche AG
Diasorin
Revvity Inc.
Thermo Fisher Scientific Inc.

These companies continue to lead the market by introducing advanced genetic testing products and collaborating with healthcare providers to expand the availability of testing services. In October 2023, 23andMe announced a collaboration with GSK plc, marking a significant step in advancing genetic testing for drug target discovery.

Global Schizophrenia Drugs Market

Oncology Precision Medicine Market

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 15 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.

Media Contact:

Company Name: Renub Research

Contact Person: Rajat Gupta, Marketing Manager

Phone No: +91-120-421-9822 (IND) | +1-478-202-3244 (USA)

Email: mailto:rajat@renub.com